{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:33:53Z","timestamp":1781706833041,"version":"3.54.5"},"reference-count":17,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,31]]},"abstract":"<jats:p>In 2015\/16, the influenza season in the United Kingdom was dominated by influenza A(H1N1)pdm09 circulation. Virus characterisation indicated the emergence of genetic clusters, with the majority antigenically similar to the current influenza A(H1N1)pdm09 vaccine strain. Mid-season vaccine effectiveness (VE) estimates show an adjusted VE of 41.5% (95% confidence interval (CI): 3.0\u201364.7) against influenza-confirmed primary care consultations and of 49.1% (95% CI: 9.3\u201371.5) against influenza A(H1N1)pdm09. These estimates show levels of protection similar to the 2010\/11 season, when this strain was first used in the seasonal vaccine.<\/jats:p>","DOI":"10.2807\/1560-7917.es.2016.21.13.30179","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T22:50:06Z","timestamp":1460155806000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":18,"title":["Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 mid-season results"],"prefix":"10.2807","volume":"21","author":[{"given":"Richard","family":"Pebody","sequence":"first","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Warburton","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ellis","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Potts","sequence":"additional","affiliation":[{"name":"Health Protection Scotland, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Public Health Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Johnston","sequence":"additional","affiliation":[{"name":"Public Health Agency Northern Ireland, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Health Protection Scotland, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Gunson","sequence":"additional","affiliation":[{"name":"West of Scotland Specialist Virology Centre, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thompson","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Galiano","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Robertson","sequence":"additional","affiliation":[{"name":"University of Strathclyde, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mullett","sequence":"additional","affiliation":[{"name":"University of Surrey, Guildford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomh","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Public Health Agency Northern Ireland, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sinnathamby","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivelina","family":"Yonova","sequence":"additional","affiliation":[{"name":"University of Surrey, Guildford, United Kingdom"},{"name":"Royal College of General Practitioners, Research and Surveillance Centre, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Moore","sequence":"additional","affiliation":[{"name":"Public Health Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"McMenamin","sequence":"additional","affiliation":[{"name":"Health Protection Scotland, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[{"name":"University of Surrey, Guildford, United Kingdom"},{"name":"Royal College of General Practitioners, Research and Surveillance Centre, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zambon","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7995","reference":[{"key":"#cr-split#-r1.1","unstructured":"Hakin B, Cosford P, Harvey F. The flu immunisation programme 2013\/14- extension to children. London: Department of Health"},{"key":"#cr-split#-r1.2","unstructured":"26 Jul 2013. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/225360\/Children_s_flu_letter_2013.pdf"},{"key":"#cr-split#-r2.1","unstructured":"Public Health England (PHE). PHE weekly national influenza report. Summary of UK surveillance of influenza and other seasonal respiratory illnesses 17 March 2016 - Week 11 report (up to week 10 data). London: PHE"},{"key":"#cr-split#-r2.2","unstructured":"17 Mar 2016. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/508660\/Weekly_report_current_wk_11_17Mar2016.pdf"},{"issue":"12","key":"r3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/jech.2009.093450","article-title":"Estimating influenza vaccine effectiveness using routinely collected laboratory data.","volume":"64","author":"Fleming","year":"2010","journal-title":"J Epidemiol Community Health"},{"issue":"27","key":"r4","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.2807\/1560-7917.ES2014.19.27.20851","article-title":"Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012\/13 end of season results.","volume":"19","author":"Andrews","year":"2014","journal-title":"Euro Surveill"},{"issue":"22","key":"r5","doi-asserted-by":"crossref","first-page":"19230","DOI":"10.2807\/ese.14.22.19230-en","article-title":"Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses.","volume":"14","author":"Ellis","year":"2009","journal-title":"Euro Surveill"},{"issue":"2","key":"r6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jviromet.2009.10.006","article-title":"Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A\/H1N1\/2009 virus.","volume":"163","author":"Gunson","year":"2010","journal-title":"J Virol Methods"},{"issue":"8","key":"r7","doi-asserted-by":"crossref","first-page":"e23779","DOI":"10.1371\/journal.pone.0023779","article-title":"Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK.","volume":"6","author":"Galiano","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"r8","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/JVI.77.15.8418-8425.2003","article-title":"Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.","volume":"77","author":"Matrosovich","year":"2003","journal-title":"J Virol"},{"key":"r9","unstructured":"Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. pp. 291-313."},{"issue":"12","key":"r10","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"r11","unstructured":"European Centre for Disease Prevention and Control (ECDC). Seasonal influenza 2015\u201316 in the EU\/EEA countries. Stockholm: ECDC; 2016. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/seasonal-influenza-risk-assessment-2015-2016.pdf"},{"issue":"6","key":"r12","doi-asserted-by":"crossref","first-page":"19791","DOI":"10.2807\/ese.16.06.19791-en","article-title":"Effectiveness of seasonal 2010\/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010\/11.","volume":"16","author":"Pebody","year":"2011","journal-title":"Euro Surveill"},{"issue":"6","key":"r13","doi-asserted-by":"crossref","first-page":"30134","DOI":"10.2807\/1560-7917.ES.2016.21.6.30134","article-title":"Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study.","volume":"21","author":"Kissling","year":"2016","journal-title":"Euro Surveill"},{"issue":"11","key":"r14","doi-asserted-by":"crossref","first-page":"30168","DOI":"10.2807\/1560-7917.ES.2016.21.11.30168","article-title":"Interim estimates of 2015\/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.","volume":"21","author":"Chambers","year":"2016","journal-title":"Euro Surveill"},{"key":"r15","unstructured":"World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2016-17 northern hemisphere influenza season. Geneva: WHO; 25 February 2016. Available from: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/2016_17_north\/en\/"}],"container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:02:23Z","timestamp":1663243343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2016.21.13.30179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":17,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3,31]]}},"URL":"https:\/\/doi.org\/10.2807\/1560-7917.es.2016.21.13.30179","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}